The Signoria Creation IPO is a closed SME Mainboard offer (Fresh Capital) that opened on 12 March 2024. The Signoria Creation IPO closed on 14 March 2024, with an issue price of ₹65 per share. The Signoria Creation IPO has a face value of ₹10 and a lot size of 2,000 shares. The Signoria Creation IPO is listed on 19 March 2025. The Signoria Creation IPO allotment was scheduled for 15 March 2024.
On the financial front, the Signoria Creation IPO reported revenue of ₹653 for 30 Sep 2023, compared with ₹1,916 for 31 Mar 2023. The Signoria Creation IPO PAT was ₹65 against ₹231. The Signoria Creation IPO net worth as of 30 Sep 2023 was ₹648.
Always verify The Signoria Creation IPO details and GMP data with the official offer document before investing in the Signoria Creation IPO.
Financial Summary
Amount in ₹ Lakhs
Metric
30 Sep 2023
31 Mar 2023
31 Mar 2022
Total Assets
2,615
2,335
951
Revenue
653
1,916
1,182
PAT
65
231
68
Net Worth
648
583
151
Reserves
537
472
101
Total Borrowing
1,264
1,050
-377
Signoria Creation IPO Financials FAQs
Revenue of Signoria Creation (Amount in ₹ Lakhs) — 30 Sep 2023: 653; 31 Mar 2023: 1,916; 31 Mar 2022: 1,182. Profit after tax (PAT) — 30 Sep 2023: 65; 31 Mar 2023: 231; 31 Mar 2022: 68.
Total assets — 30 Sep 2023: 2,615; 31 Mar 2023: 2,335; 31 Mar 2022: 951. Net worth — 30 Sep 2023: 648; 31 Mar 2023: 583; 31 Mar 2022: 151. Reserves & surplus — 30 Sep 2023: 537; 31 Mar 2023: 472; 31 Mar 2022: 101. (Amount in ₹ Lakhs)
Total borrowing of Signoria Creation (Amount in ₹ Lakhs) — 30 Sep 2023: 1,264; 31 Mar 2023: 1,050; 31 Mar 2022: -377.
The financials shown for Signoria Creation IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
